The deal, which is valued at $6.65 a share, is a 28% premium from Infinera’s stock price at the close of trading on Wednesday.
Related Posts
Decision Time for GM in China: Stay, Scale Back or Go
The country’s sharp shift to EVs and stronger local competition have deflated a key profit engine for the U.S. automaker.
FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the […]
Tate & Lyle Buys CP Kelco for $1.8 Billion
Tate & Lyle agreed to buy the nature-based ingredients provider as the U.K. group jockeys for position in a highly competitive market to meet demand […]